MidWestOne Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

MidWestOne Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$435K	Sell	563 -534	-49%	-$363K	0.05%	219
2025 Q3	$617K	Buy	1,097 +708	+182%	+$400K	0.07%	194
2025 Q2	$204K	Buy	+389	New	+$217K	0.03%	281
2022 Q4	–	Sell	-1,123	Closed	-$774K	–	249
2022 Q3	$774K	Sell	1,123 -5	-0.4%	-$3.15K	0.2%	123
2022 Q2	$667K	Sell	1,128 -22	-2%	-$14.3K	0.17%	131
2022 Q1	$803K	Buy	1,150 +35	+3%	+$22.1K	0.17%	135
2021 Q4	$704K	Buy	1,115 +131	+13%	+$80.5K	0.15%	151
2021 Q3	$595K	Buy	984 +26	+3%	+$16.1K	0.14%	146
2021 Q2	$535K	Sell	958 -19	-2%	-$9.63K	0.13%	149
2021 Q1	$462K	Buy	977 +414	+74%	+$202K	0.11%	155
2020 Q4	$272K	Sell	563 -239	-30%	-$129K	0.07%	180
2020 Q3	$449K	Buy	+802	New	+$486K	0.15%	149

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MidWestOne Financial Group's REGN Position: Q4 2025 in Review

MidWestOne Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 49% in Q4 2025, selling an estimated $363K and leaving 563 shares worth $435K. The position accounts for 0.05% of the portfolio, ranked #219.

MidWestOne Financial Group first reported a position in REGN in Q3 2020 and has held it in 12 quarters since. The position peaked at $803K in Q1 2022. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

MidWestOne Financial Group held 563 shares of Regeneron Pharmaceuticals worth $435K as of Q4 2025.
MidWestOne Financial Group sold 534 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $363K.
Regeneron Pharmaceuticals made up 0.05% of MidWestOne Financial Group's portfolio in Q4 2025, its #219 holding.
MidWestOne Financial Group first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 12 quarters since.
MidWestOne Financial Group's Regeneron Pharmaceuticals position peaked at $803K in Q1 2022.
1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.